Other News To Note
Wednesday, December 21, 2011
Antares Pharma Inc., of Ewing, N.J., has licensed to Pfizer Inc.'s Consumer Healthcare Business Unit one of its drug delivery technologies to develop an undisclosed product on an exclusive basis for North America. New York-based Pfizer will assume full cost and responsibility for all clinical development, manufacturing and commercialization of the product in the licensed territory, which also includes certain nonexclusive territories outside of North America. Antares will receive undisclosed up-front payments, development milestones and sales-based milestones, as well as royalties on net sales for three years post-launch in the U.S.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.